Adverse events in rheumatoid arthritis patients under antimalarial treatment—Is there cardiovascular compromise?

Adverse events in rheumatoid arthritis patients under antimalarial treatment—Is there cardiovascular compromise?

Introduction: The antimalarials chloroquine and hydroxychloroquine have been used for several decades in treating malaria and some autoimmune diseases—mainly rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)—with excellent efficacy and safety. Due to the massive use of antimalarials w...

Full description

Saved in:
Bibliographic Details
Main Authors: Pedro Santos-Moreno, Linda Ibatá, Susan Martínez, Gabriel-Santiago Rodríguez-Vargas, Laura Villarreal, Pedro Rodríguez, Wilberto Rivero, Fernando Rodríguez-Florido, Adriana Rojas-Villarraga
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Drug Safety and Regulation
Subjects:
pharmacovigilance
antimalarials
rheumatoid arthritis
drug-related side effects
cardiotoxicity
Online Access:https://www.frontiersin.org/articles/10.3389/fdsfr.2022.1044696/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fdsfr.2022.1044696/full

Similar Items